Thus, the identification of CaMKII as a regulator of TJ functions and its functional analysis in this study are important first steps in expanding the study of the epithelial barrier and developing therapeutic strategies for diseases caused by defective epithelial barrier function, such as inflammatory bowel disease, asthma or atopic dermatitis. Here, CAMK2G is linked to atopic eczema.